Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001564590-17-004536
Filing Date
2017-03-16
Accepted
2017-03-16 08:00:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 8-K mstx-8k_20170316.htm 425 38359
2 EX-99.1 mstx-ex991_6.htm EX-99.1 34228
3 GRAPHIC g2017031602172554243500.jpg GRAPHIC 4304
4 GRAPHIC g2017031602172554443501.jpg GRAPHIC 5469
  Complete submission text file 0001564590-17-004536.txt   88393
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filed by) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-32157 | Film No.: 17692916
SIC: 2834 Pharmaceutical Preparations